Literature DB >> 7496953

Comparative analysis of antibodies to Francisella tularensis antigens during the acute phase of tularemia and eight years later.

L Bevanger1, J A Maeland, A I Kvan.   

Abstract

Approximately 8 years after treatment for tularemia, 14 of 22 (63.6%) individuals tested still had a positive microagglutination test for Francisella tularensis antibodies. An enzyme-linked immunosorbent assay for anti-F. tularensis outer membrane antibodies was positive for 55% (immunoglobulin A [IgA]), 95% (IgG), and 27% (IgM) of the late-phase sera, but with antibody levels significantly reduced from those in the acute-phase sera. IgG and IgA antibody levels in the late-phase sera showed significant correlation with levels in the acute-phase sera. The IgG/IgM ratio calculation discriminated between acute-phase and persistent antibodies for most sera, but Western blot (immunoblot) patterns did not. Immunoblotting indicated that the F. tularensis lipopolysaccharide is a major target for antibodies in both groups of sera. Our results substantiate the need for caution in the interpretation of positive serological test results for tularemia, which could result from disease occurring years earlier.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7496953      PMCID: PMC368235          DOI: 10.1128/cdli.1.2.238-240.1994

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  8 in total

1.  Agglutinins and antibodies to Francisella tularensis outer membrane antigens in the early diagnosis of disease during an outbreak of tularemia.

Authors:  L Bevanger; J A Maeland; A I Naess
Journal:  J Clin Microbiol       Date:  1988-03       Impact factor: 5.948

2.  Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis.

Authors:  K Granfors; S Jalkanen; A A Lindberg; O Mäki-Ikola; R von Essen; R Lahesmaa-Rantala; H Isomäki; R Saario; W J Arnold; A Toivanen
Journal:  Lancet       Date:  1990-03-24       Impact factor: 79.321

3.  Enzyme-linked immunosorbent assay for immunological diagnosis of human tularemia.

Authors:  H E Carlsson; A A Lindberg; G Lindberg; B Hederstedt; K A Karlsson; B O Agell
Journal:  J Clin Microbiol       Date:  1979-11       Impact factor: 5.948

4.  Humoral immunity against Francisella tularensis after natural infection.

Authors:  P Koskela; A Salminen
Journal:  J Clin Microbiol       Date:  1985-12       Impact factor: 5.948

5.  Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory-acquired tularemia.

Authors:  D S Burke
Journal:  J Infect Dis       Date:  1977-01       Impact factor: 5.226

6.  Production and characterization of monoclonal antibodies directed against the lipopolysaccharide of Francisella tularensis.

Authors:  M J Fulop; T Webber; R J Manchee; D C Kelly
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

7.  Cell-mediated and humoral immune responses induced by scarification vaccination of human volunteers with a new lot of the live vaccine strain of Francisella tularensis.

Authors:  D M Waag; A Galloway; G Sandstrom; C R Bolt; M J England; G O Nelson; J C Williams
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

8.  Yersinia antigens in synovial-fluid cells from patients with reactive arthritis.

Authors:  K Granfors; S Jalkanen; R von Essen; R Lahesmaa-Rantala; O Isomäki; K Pekkola-Heino; R Merilahti-Palo; R Saario; H Isomäki; A Toivanen
Journal:  N Engl J Med       Date:  1989-01-26       Impact factor: 91.245

  8 in total
  11 in total

1.  Detoxified endotoxin vaccine (J5dLPS/OMP) protects mice against lethal respiratory challenge with Francisella tularensis SchuS4.

Authors:  Stephen H Gregory; Wilbur H Chen; Stephanie Mott; John E Palardy; Nicholas A Parejo; Sara Heninger; Christine A Anderson; Andrew W Artenstein; Steven M Opal; Alan S Cross
Journal:  Vaccine       Date:  2010-02-17       Impact factor: 3.641

2.  Kinetics of the immune response associated with tularemia: comparison of an enzyme-linked immunosorbent assay, a tube agglutination test, and a novel whole-blood lymphocyte stimulation test.

Authors:  Henrik Eliasson; Per Olcén; Anders Sjöstedt; Margareta Jurstrand; Erik Bäck; Sören Andersson
Journal:  Clin Vaccine Immunol       Date:  2008-06-18

3.  Evaluation of an immunochromatographic test for rapid and reliable serodiagnosis of human tularemia and detection of Francisella tularensis-specific antibodies in sera from different mammalian species.

Authors:  W Splettstoesser; V Guglielmo-Viret; E Seibold; P Thullier
Journal:  J Clin Microbiol       Date:  2010-03-10       Impact factor: 5.948

4.  Comparison of enzyme-linked immunosorbent assay, Western blotting, microagglutination, indirect immunofluorescence assay, and flow cytometry for serological diagnosis of tularemia.

Authors:  Mustafa Porsch-Ozcürümez; Nele Kischel; Heidi Priebe; Wolf Splettstösser; Ernst-Jürgen Finke; Roland Grunow
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

5.  Evaluation of In-House and Commercial Serological Tests for Diagnosis of Human Tularemia.

Authors:  Hadjila Yanes; Aurélie Hennebique; Isabelle Pelloux; Sandrine Boisset; Dominique J Bicout; Yvan Caspar; Max Maurin
Journal:  J Clin Microbiol       Date:  2017-12-26       Impact factor: 5.948

6.  Towards Development of Improved Serodiagnostics for Tularemia by Use of Francisella tularensis Proteome Microarrays.

Authors:  Rie Nakajima; Raquel Escudero; Douglas M Molina; Manuela Rodríguez-Vargas; Arlo Randall; Algis Jasinskas; Jozelyn Pablo; Philip L Felgner; David P AuCoin; Pedro Anda; D Huw Davies
Journal:  J Clin Microbiol       Date:  2016-04-20       Impact factor: 5.948

7.  Detection of Francisella tularensis-specific antibodies in patients with tularemia by a novel competitive enzyme-linked immunosorbent assay.

Authors:  Neekun Sharma; Akitoyo Hotta; Yoshie Yamamoto; Osamu Fujita; Akihiko Uda; Shigeru Morikawa; Akio Yamada; Kiyoshi Tanabayashi
Journal:  Clin Vaccine Immunol       Date:  2012-10-31

8.  A combined enrichment and aptamer pulldown assay for Francisella tularensis detection in food and environmental matrices.

Authors:  Elise A Lamont; Ping Wang; Shinichiro Enomoto; Klaudyna Borewicz; Ahmed Abdallah; Richard E Isaacson; Srinand Sreevatsan
Journal:  PLoS One       Date:  2014-12-23       Impact factor: 3.240

9.  Protective effects of the Francisella tularensis ΔpdpC mutant against its virulent parental strain SCHU P9 in Cynomolgus macaques.

Authors:  Deyu Tian; Akihiko Uda; Yasushi Ami; Akitoyo Hotta; Eun-Sil Park; Noriyo Nagata; Naoko Iwata-Yoshikawa; Akio Yamada; Kazuhiro Hirayama; Kozue Miura; Yuki Koyama; Mika Azaki; Shigeru Morikawa
Journal:  Sci Rep       Date:  2019-06-24       Impact factor: 4.379

10.  Cross Sectional Study and Risk Factors Analysis of Francisella tularensis in Soil Samples in Punjab Province of Pakistan.

Authors:  Javed Muhammad; Masood Rabbani; Muhammad Zubair Shabbir; Khushi Muhammad; Muhammad Taslim Ghori; Haroon Rashid Chaudhry; Zia Ul Hassnain; Tariq Jamil; Tariq Abbas; Muhammad Hamid Chaudhry; Muhammad Haisem-Ur-Rasool; Muhammad Asad Ali; Muhammad Nisar; Girish S Kirimanjeswara; Bhushan M Jayarao
Journal:  Front Cell Infect Microbiol       Date:  2019-04-05       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.